Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000235390

Medchemexpress LLC N-hydroxy-4-((quinolin-8-ylamino)methyl)benzamide | 2151853-97-1 | 99.8% | 293.32 g·mol-1 | C17H15N3O2 | 10MG
SDP

Supplier:  Medchemexpress LLC HY12397610MG

Encompass_Preferred

MPT0G211 is a potent, orally active, and selective HDAC6 inhibitor intended for preclinical research applications. It is used in biochemical and cellular studies to probe HDAC6-related pathways relevant to neurodegeneration and oncology, and is characterized by sub-nanomolar potency and high chemical purity.

  • Selective HDAC6 inhibition (IC50 0.291 nM).
  • Sub-nanomolar potency suitable for biochemical assays.
  • High purity, 99.8%.
  • Suitable for in vitro and in vivo preclinical studies.
  • Soluble in DMSO for stock solution preparation.
  • Available in small research pack sizes for screening and confirmation studies.

Catalog No. 50-002-35390


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.